Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print February 22, 2007
DOI: 10.2337/db06-1746

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1746v1
56/5/1357    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masia, R.
Right arrow Articles by Nichols, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masia, R.
Right arrow Articles by Nichols, C. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

A mutation in the TMD0-L0 region of SUR1 (L225P) causes Permanent Neonatal Diabetes Mellitus (PNDM)

Ricard Masia1, Diva D. DeLeon2, Courtney MacMullen2, Heather McKnight2, Charles A. Stanley2, and Colin G. Nichols1

1Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110
2Division of Endocrinology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104

Correspondence: cnichols{at}wustl.edu

Key Words: Neonatal Diabetes • KATP • SUR1 • sulfonylurea

Objective. To examine the molecular mechanisms underlying Persistent Neonatal Diabetes Mellitus (PNDM) in a patient with a heterozygous de novo L225P mutation in the L0 region of the sulfonylurea receptor (SUR1), the regulatory subunit of the pancreatic ATP-sensitive K+ (KATP) channel.

Research Design and Methods. The effects of L225P on the properties of recombinant KATP channels in transfected COS cells were assessed by patch-clamp experiments on excised membrane patches and by macroscopic Rb-flux experiments in intact cells.

Results. L225P-containing KATP channels were significantly more active in the intact cell than WT channels. In excised membrane patches, L225P increased channel sensitivity to stimulatory Mg-nucleotides without altering intrinsic gating or channel inhibition by ATP in the absence of Mg2+. The effects of L225P were abolished by SUR1 mutations that prevent nucleotide hydrolysis at the Nucleotide Binding Folds. L225P did not alter channel inhibition by sulfonylurea drugs, and, consistent with this, the patient responded to treatment with oral sulfonylureas.

Conclusions. L225P underlies KATP channel overactivity and PNDM by specifically increasing Mg-nucleotide stimulation of the channel, consistent with recent reports of mechanistically similar PNDM-causing mutations in SUR1. The mutation does not affect sulfonylurea sensitivity and the patient is successfully treated with sulfonylureas.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. I. Tarasov, T. J. Nicolson, J.-P. Riveline, T. K. Taneja, S. A. Baldwin, J. M. Baldwin, G. Charpentier, J.-F. Gautier, P. Froguel, M. Vaxillaire, et al.
A Rare Mutation in ABCC8/SUR1 Leading to Altered ATP-Sensitive K+ Channel Activity and {beta}-Cell Glucose Sensing Is Associated With Type 2 Diabetes in Adults
Diabetes, June 1, 2008; 57(6): 1595 - 1604.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. P.H. Shield, S. E. Flanagan, D. J. Mackay, L. W. Harries, P. Proks, C. Girard, F. M. Ashcroft, I. K. Temple, and S. Ellard
Mosaic Paternal Uniparental Isodisomy and an ABCC8 Gene Mutation in a Patient With Permanent Neonatal Diabetes and Hemihypertrophy
Diabetes, January 1, 2008; 57(1): 255 - 258.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Proks, K. Shimomura, T. J. Craig, C. A.J. Girard, and F. M. Ashcroft
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome
Hum. Mol. Genet., August 15, 2007; 16(16): 2011 - 2019.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.